Skip to main content
David Schuster, MD, Radiology, Atlanta, GA, Emory University Hospital

DavidMichaelSchusterMD

Radiology Atlanta, GA

Nuclear Cardiology, Nuclear Medicine, Nuclear Radiology

Professor, Radiology & Imaging Sciences, Emory University School of Medicine

Dr. Schuster is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Schuster's full profile

Already have an account?

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterResidency, Radiology, 1988 - 1992
  • Albany Medical Center
    Albany Medical CenterInternship, Internal Medicine, 1987 - 1988
  • Albany Medical College
    Albany Medical CollegeClass of 1987

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1998 - 2022
  • GA State Medical License
    GA State Medical License 1996 - 2023
  • MA State Medical License
    MA State Medical License 1988 - 1997
  • American Board of Nuclear Medicine Nuclear Medicine
  • American Board of Radiology Diagnostic Radiology
  • American Board of Radiology Nuclear Radiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Imaging of Prostate Cancer Using Fluciclovine  
    David Schuster, MD, ScienceDirect

Authored Content

  • Y90 Radioembolization Dosimetry Using a Simple Semi-Quantitative Method in Intrahepatic Cholangiocarcinoma: Glass Versus Resin MicrospheresJanuary 2018

Press Mentions

  • Telix Pharmaceuticals and Emory Winship Cancer Institute to Collaborate on Clinical Trial Using Advanced Imaging of Prostate Cancer for Radiotherapy
    Telix Pharmaceuticals and Emory Winship Cancer Institute to Collaborate on Clinical Trial Using Advanced Imaging of Prostate Cancer for RadiotherapyMay 30th, 2019
  • FDA Approves Emory-Developed Prostate Cancer Imaging Probe
    FDA Approves Emory-Developed Prostate Cancer Imaging ProbeJune 1st, 2016
  • Radiotracer Use Boosts Prostate Cancer Outcomes
    Radiotracer Use Boosts Prostate Cancer OutcomesMay 15th, 2021

Grant Support

  • Anti-[18 F] Facbc PET-CT For Characterization Of Primary Prostate CarcinomaNational Cancer Institute2008–2011
  • 18f-Facbc PET-CT For The Detection And Staging Of Recurrent Prostate CarcinomaNational Cancer Institute2007–2011

Hospital Affiliations